132 related articles for article (PubMed ID: 20101856)
1. Mid-trimester maternal serum markers in predicting adverse pregnancy outcome.
Androutsopoulos G; Gkogkos P; Papadopoulos V; Adonakis G; Tsapanos V; Vassilakos P; Panayiotakis G; Decavalas G
Clin Exp Obstet Gynecol; 2009; 36(4):237-40. PubMed ID: 20101856
[TBL] [Abstract][Full Text] [Related]
2. Mid-trimester maternal serum hCG levels in predicting adverse pregnancy outcome.
Androutsopoulos G; Gkogkos P; Vassilakos P; Panayiotakis G; Decavalas G
Clin Exp Obstet Gynecol; 2009; 36(3):173-5. PubMed ID: 19860362
[TBL] [Abstract][Full Text] [Related]
3. Mid-trimester maternal serum AFP levels in predicting adverse pregnancy outcome.
Gkogkos P; Androutsopoulos G; Vassilakos P; Panayiotakis G; Kourounis G; Decavalas G
Clin Exp Obstet Gynecol; 2008; 35(3):208-10. PubMed ID: 18754295
[TBL] [Abstract][Full Text] [Related]
4. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin.
Toal M; Chaddha V; Windrim R; Kingdom J
J Obstet Gynaecol Can; 2008 Mar; 30(3):198-206. PubMed ID: 18364097
[TBL] [Abstract][Full Text] [Related]
6. Uterine artery Doppler and adverse pregnancy outcome in women with extreme levels of fetoplacental proteins used for Down syndrome screening.
Filippi E; Staughton J; Peregrine E; Jones P; Huttly W; Peebles DM; Pandya P; David AL
Ultrasound Obstet Gynecol; 2011 May; 37(5):520-7. PubMed ID: 21520313
[TBL] [Abstract][Full Text] [Related]
7. The relationship between unexplained elevated serum markers in triple test, uterine artery Doppler measurements and adverse pregnancy outcome.
Karsidag AY; Buyukbayrak EE; Kars B; Suyugul U; Unal O; Turan MC
J Pak Med Assoc; 2010 Mar; 60(3):181-6. PubMed ID: 20225773
[TBL] [Abstract][Full Text] [Related]
8. Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes.
Tancrède S; Bujold E; Giguère Y; Renald MH; Girouard J; Forest JC
J Obstet Gynaecol Can; 2015 Feb; 37(2):111-6. PubMed ID: 25767942
[TBL] [Abstract][Full Text] [Related]
9. Mid-trimester placentation assessment in high-risk pregnancies using maternal serum screening and uterine artery Doppler.
Hershkovitz R; de Swiet M; Kingdom J
Hypertens Pregnancy; 2005; 24(3):273-80. PubMed ID: 16263599
[TBL] [Abstract][Full Text] [Related]
10. Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry.
Audibert F; Benchimol Y; Benattar C; Champagne C; Frydman R
Fetal Diagn Ther; 2005; 20(1):48-53. PubMed ID: 15608460
[TBL] [Abstract][Full Text] [Related]
11. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
Jauniaux E; Gulbis B; Tunkel S; Ramsay B; Campbell S; Meuris S
Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249
[TBL] [Abstract][Full Text] [Related]
12. Predictive Value of Second-Trimester Biomarkers and Maternal Features for Adverse Pregnancy Outcomes.
Yefet E; Kuzmin O; Schwartz N; Basson F; Nachum Z
Fetal Diagn Ther; 2017; 42(4):285-293. PubMed ID: 28395283
[TBL] [Abstract][Full Text] [Related]
13. [Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes].
Hu Z; Liu X; Li L; Jia C; Li D; Liu R
Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):749-53. PubMed ID: 25537246
[TBL] [Abstract][Full Text] [Related]
14. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
15. Mid-trimester maternal serum HCG and alpha fetal protein levels: clinical significance and prediction of adverse pregnancy outcome.
Androutsopoulos G; Gkogkos P; Decavalas G
Int J Endocrinol Metab; 2013; 11(2):102-6. PubMed ID: 23825981
[TBL] [Abstract][Full Text] [Related]
16. An association between fetal abdominal wall defects and elevated levels of human chorionic gonadotropin in mid-trimester.
Schmidt D; Rose E; Greenberg F
Prenat Diagn; 1993 Jan; 13(1):9-12. PubMed ID: 7680473
[TBL] [Abstract][Full Text] [Related]
17. Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening.
Berry E; Aitken DA; Crossley JA; Macri JN; Connor JM
Prenat Diagn; 1995 Jun; 15(6):555-65. PubMed ID: 7544898
[TBL] [Abstract][Full Text] [Related]
18. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein.
Benn PA; Horne D; Briganti S; Rodis JF; Clive JM
Obstet Gynecol; 1996 Feb; 87(2):217-22. PubMed ID: 8559527
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy outcomes of women with elevated second-trimester maternal serum alpha-fetoprotein.
Hu JL; Zhang YJ; Zhang JM; Zhu S; Li DM; Yin YF; Su J; Chan Y; He J; Cao YJ; Zhu BS
Taiwan J Obstet Gynecol; 2020 Jan; 59(1):73-78. PubMed ID: 32039804
[TBL] [Abstract][Full Text] [Related]
20. Maternal smoking: age distribution, levels of alpha-fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second-trimester screening.
Crossley JA; Aitken DA; Waugh SM; Kelly T; Connor JM
Prenat Diagn; 2002 Mar; 22(3):247-55. PubMed ID: 11920904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
